TrialHuman vaccines & immunotherapeutics2022

Safety, immunogenicity and non-interference of concomitant Typhoid Vi capsular polysaccharide-tetanus toxoid conjugate vaccine (Typbar-TCV®) and measles or measles-mumps-rubella vaccines in 8-9 months-old Indian children.

Krishna Mohan Vadrevu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.